Clik here to view.
Emyria and UWA in Partnership to Commercialise Novel Serotonin-Releasing...
Emyria Limited (ASX: EMD) (“Emyria”, or the “Company”) has signed an exclusive licence agreement with UWA, granting worldwide rights to a rapidly growing portfolio of selective serotonin-releasing...
View ArticleClik here to view.
Compass Pathways Announces Third Quarter 2024 Financial Results and Business...
Top-line COMP005 data for COMP360 phase 3 pivotal program in treatment-resistant depression now expected in second quarter 2025 COMP006 data will now be announced after 26-week time point, expected in...
View ArticleClik here to view.
Compass Pathways to participate in Stifel 2024 Healthcare Conference
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the...
View ArticleClik here to view.
Compass Pathways to Participate in December Investor Conferences
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that members of the executive...
View ArticleClik here to view.
Compass Pathways Announces Pricing of Underwritten Offering
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the pricing of an underwritten...
View ArticleClik here to view.
Compass Pathways Announces Pricing of Underwritten Offering
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the pricing of an underwritten...
View ArticleClik here to view.
Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer
Newly created role of Chief Patient Officer reinforces Compass' vision of working to achieve broad and equitable access to COMP360, if approved Compass Pathways plc (Nasdaq: CMPS) ("Compass"), a...
View ArticleClik here to view.
Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer
Newly created role of Chief Patient Officer reinforces Compass' vision of working to achieve broad and equitable access to COMP360, if approved Compass Pathways plc (Nasdaq: CMPS) ("Compass"), a...
View ArticleClik here to view.
Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life...
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the...
View ArticleClik here to view.
Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life...
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the...
View ArticleClik here to view.
Compass Pathways to announce fourth quarter and year-end financial results on...
Compass management will host a conference call at 8:00 am ET (1:00pm UK) Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based...
View ArticleClik here to view.
Compass Pathways to announce fourth quarter and year-end financial results on...
Compass management will host a conference call at 8:00 am ET (1:00pm UK) Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based...
View ArticleClik here to view.
Compass Pathways to announce fourth quarter and year-end financial results on...
Compass management will host a conference call at 8:00 am ET (1:00pm UK) Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based...
View ArticleClik here to view.
Compass Pathways to announce fourth quarter and year-end financial results on...
Compass management will host a conference call at 8:00 am ET (1:00pm UK) Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based...
View ArticleClik here to view.
Compass Pathways to announce fourth quarter and year-end financial results on...
Compass management will host a conference call at 8:00 am ET (1:00pm UK) Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based...
View ArticleClik here to view.
Compass Pathways to announce fourth quarter and year-end financial results on...
Compass management will host a conference call at 8:00 am ET (1:00pm UK) Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based...
View ArticleClik here to view.
Compass Pathways to announce fourth quarter and year-end financial results on...
Compass management will host a conference call at 8:00 am ET (1:00pm UK) Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based...
View ArticleClik here to view.
Compass Pathways to announce fourth quarter and year-end financial results on...
Compass management will host a conference call at 8:00 am ET (1:00pm UK) Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based...
View ArticleClik here to view.
Compass Pathways to announce fourth quarter and year-end financial results on...
Compass management will host a conference call at 8:00 am ET (1:00pm UK) Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based...
View ArticleClik here to view.
Compass Pathways to announce fourth quarter and year-end financial results on...
Compass management will host a conference call at 8:00 am ET (1:00pm UK) Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based...
View Article